Twist Bioscience to Become a Voting Member of the Storage Networking Industry Association | News

0

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–April 21, 2022–

Twist Bioscience Corporation (NASDAQ: TWST), a company that enables customers to succeed through its high-quality synthetic DNA offering using its silicon platform, today announced that it has joined the Storage Networking Industry Association (SNIA www.snia.org ) as a voting member. SNIA is a not-for-profit organization comprised of storage professionals and is the globally recognized and trusted authority for storage leadership, standards, and technology expertise.

“DNA offers an innovative approach to long-term data storage, as it provides a medium for data that will have reading capabilities as humanity continues to explore our living environment and the mysteries of our own. DNA,” Michael said. Oros, Executive Director, SNIA. “We believe the industry as a whole will be eager to explore the standards of a new storage medium that will solve the conundrum of having a device 100 years from now to play archived media today.”

“The charter of the SNIA Data Protection and Privacy Committee (DPPC) is to broaden awareness and adoption of data protection technology, and to provide education, best practices and technology guidance on all issues related to data protection and privacy. We believe that DNA provides a long-term data storage medium to be considered under this charter and we welcome Twist Bioscience as a voting member of SNIA,” commented Pushpendra Kumar “PK Gupta, co-chair, SNIA DPPC.

“SNIA is the storage industry leader in developing and promoting vendor-neutral architectures, standards, and educational services for storage professionals worldwide,” said Emily M. Leproust, Ph. D., CEO and co-founder of Twist. “We are committed to actively participating and engaging with the group as a voting member to help guide the implementation of new standards for the storage industry.”

About Twist Bioscience

Twist Biosciences is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is proprietary technology that pioneers a new method of making synthetic DNA by “writing” DNA onto a silicon chip. Twist leverages its unique technology to manufacture a wide range of synthetic DNA products, including synthetic genes, tools for Next Generation Sequencing (NGS) preparation, and antibody libraries for discovery and drug development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologic drug discovery. Twist manufactures products for many industries including healthcare, industrial chemicals, agriculture and academic research.

Legal notice regarding forward-looking statements

This press release contains forward-looking statements. All statements other than statements of historical fact contained herein are forward-looking statements reflecting management’s current beliefs and expectations made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause Twist Bioscience’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. forward-looking statements. For a description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Twist Bioscience’s business generally, see Twist Bioscience’s risk factors set forth in the Twist Bioscience quarterly report form. 10-Q filed with the Securities and Exchange Commission on February 9, 2022 and subsequent filings with the SEC. All forward-looking statements contained in this press release speak only as of the date hereof, and Twist Bioscience specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220421005163/en/

CONTACT: Angela Bitting

SVP, Corporate Affairs

Twist Biosciences

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

KEYWORD INDUSTRY: RESEARCH GENE TECHNOLOGY NANOTECHNOLOGY BIOTECHNOLOGY PHARMACEUTICAL HEALTH DATA MANAGEMENT SCIENCE OTHER SCIENCES

SOURCE: Twist Bioscience Corporation

Copyright BusinessWire 2022.

PUBLISHED: 04/21/2022 08:00 AM / DISK: 04/21/2022 08:02 AM

http://www.businesswire.com/news/home/20220421005163/en

Copyright BusinessWire 2022.

Share.

About Author

Comments are closed.